Evidence map›Paper›PMID 35488210›Full record

ArticleBMC genomics2022

NGS-based targeted sequencing identified two novel variants in Southwestern Chinese families with oculocutaneous albinism.

Yuanyuan Xiao, Cong Zhou, Hanbing Xie, Shuang Huang, Jing Wang, Shanling Liu

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yuanyuan XiaoDepartment of Obstetrics and Gynecology, West China Second University Hospital of Sichuan University, Chengdu, 610041, China.
Cong ZhouDepartment of Obstetrics and Gynecology, West China Second University Hospital of Sichuan University, Chengdu, 610041, China.
Hanbing XieDepartment of Obstetrics and Gynecology, West China Second University Hospital of Sichuan University, Chengdu, 610041, China.
Shuang HuangDepartment of Obstetrics and Gynecology, West China Second University Hospital of Sichuan University, Chengdu, 610041, China.
Jing WangDepartment of Obstetrics and Gynecology, West China Second University Hospital of Sichuan University, Chengdu, 610041, China. hhwj_123@163.com.
Shanling LiuDepartment of Obstetrics and Gynecology, West China Second University Hospital of Sichuan University, Chengdu, 610041, China. sunny630@126.com.
Sichuan University · CN

Funding

National Key Research and Development Program of China 2021YFC1005300National Natural Science Foundation of China 82003358Science and Technology Department of Sichuan Province 2021YFS0078
6 · The paper itself

Abstract

backgroundOculocutaneous albinism (OCA) is a group of heterogeneous genetic diseases characterized by a reduction or complete lack of pigmentation in the hair, skin, and eyes. It is associated with reduced visual acuity, nystagmus, photophobia, and strabismus. OCA type 1 (OCA1) and type 2 (OCA2) are caused by mutations in the tyrosinase (TYR) and OCA2 genes, which are responsible for most cases of OCA. The present study aimed to identify the mutational spectra of 18 southwest Chinese probands with OCA.

resultsWe used a skin disease-targeted panel to sequence more than 400 genes, including 23 genes (TYR, OCA2, AP3B1, BLOC1S3, BLOC1S6, C10orf11, DTNBP1, FRMD7, GPR143, HPS1, HPS3, HPS4, HPS5, HPS6, LYST, MC1R, MITF, MLPH, MYO5A, RAB27A, SLC24A5, SLC45A2, TYRP1) associated with syndromic and non-syndromic albinism. The targeted panel was applied to 18 patients from southwest China, nine (50%) patients were diagnosed with OCA1, and nine (50%) were diagnosed with OCA2. Our data indicate that OCA1 and OCA2, the most common subtypes, probably have the same prevalence in southwest China. In total, we identified 26 variants in TYR and OCA2 from 18 OCA cases using the NGS technology, including 24 variants presented in the Human Gene Mutation Database Professional (HGMD) and two novel variants, c.559_560insCATTATTATGTGTCAAATTATCCCC in TYR and c.1514 T > C in OCA2, which have not been previously reported. According to the American College of Medical Genetics and Genomics (ACMG) classification, c.559_560insCATTATTATGTGTCAAATTATCCCC (p.G190Cfs*12) is classified as a pathogenic variant, and c.1514 T > C (p.F505S) is evaluated as a likely pathogenic variant.

conclusionsTwo novel variants were identified which will expand the mutational spectra of TYR and OCA2. The results of the present study may have implications for genetic counseling, carrier screening, and clinical management of the disease.

Indexed as

Albinism, OculocutaneousMembrane Transport ProteinsAsian PeopleCytoskeletal ProteinsHumansMembrane ProteinsMonophenol MonooxygenaseCytoskeletal ProteinsFRMD7 protein, humanMembrane ProteinsMembrane Transport ProteinsMonophenol MonooxygenaseMedical genomicsNucleotide variationsOCA2Oculocutaneous albinismTargeted NGSTYR

Identifiers

PMID35488210
PMCPMC9055679
OpenAlexW4225089285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.